Related Experiment Video
Updated: Mar 15, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Pregnane X Receptor and Cancer: Context-Specificity is Key
Satyanarayana R Pondugula1, Petr Pavek2, Sridhar Mani3
1Department of Anatomy, Physiology and Pharmacology, Auburn University, Auburn, AL 36849, USA; Auburn University Research Initiative in Cancer, Auburn University, Auburn, AL 36849, USA.
Pregnane X receptor (PXR) influences cancer growth and chemotherapy effectiveness. Targeting PXR in specific cancers may offer new therapeutic strategies.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Pregnane X receptor (PXR) is a nuclear receptor activated by various compounds, crucial for drug metabolism in the liver and intestines.
- PXR is increasingly recognized for its role in cancer development and response to chemotherapy.
- Its expression in various cancer tissues highlights its potential as a therapeutic target.
Purpose of the Study:
- To review the diverse roles of PXR in different cancer types.
- To explore PXR's involvement in cancer cell proliferation, metastasis, and apoptosis.
- To discuss PXR's impact on chemotherapy outcomes and identify future research directions.
Main Methods:
- Literature review focusing on PXR's function in cancer.
- Analysis of PXR's regulatory role in drug metabolism and cancer-related pathways.
- Examination of PXR's involvement in prostate, breast, ovarian, endometrial, and colon cancers.
Main Results:
- PXR regulates genes involved in drug metabolism, transport, proliferation, metastasis, apoptosis, inflammation, and oxidative stress in cancer cells.
- Evidence suggests PXR plays a differential role in the growth and progression of various cancers.
- PXR activity significantly impacts the efficacy of chemotherapy treatments.
Conclusions:
- PXR exhibits a complex and varied role across different cancer types.
- Understanding PXR's specific functions in PXR-expressing cancers is critical.
- Development of selective PXR modulators is needed for targeted cancer therapy.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Dose-Response Relationship: Selectivity and Specificity

